A Qualitative Study Exploring Access to Mental Health and Substance Use Support among Individuals Experiencing Homelessness during COVID-19.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
15 03 2022
Historique:
received: 17 02 2022
revised: 11 03 2022
accepted: 12 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

People experiencing homelessness have higher rates of mental ill-health and substance use and lower access to health services compared to the general population. The COVID-19 pandemic led to changes in service delivery across health and social care services, with many adopting virtual or telephone support for service users. This paper explores the experiences of access to community-based mental health and substance use support for people experiencing homelessness during the COVID-19 pandemic. Qualitative telephone interviews were conducted with 10 women and 16 men (ages 25 to 71) who self-identified as experiencing homelessness in North East England between February and May 2021. With five individuals with lived experience, results were analysed using inductive reflexive thematic analysis. Reactive changes to support provision often led to inadvertent exclusion. Barriers to access included: physical locations, repetition of recovery stories, individual readiness, and limited availability. Participants suggested creating services reflective of need and opportunities for choice and empowerment. Community mental health and substance use support for people experiencing homelessness should ensure the support is personalised, responsive to need, inclusive, and trauma-informed. The findings of this research have important implications for mental health and substance use policy and practice for individuals who experience homelessness during a public health crisis.

Identifiants

pubmed: 35329147
pii: ijerph19063459
doi: 10.3390/ijerph19063459
pmc: PMC8950841
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom
Organisme : National Institute for Health Research (NIHR) School for Public Health Research (SPHR)
ID : PD-SPH-2015
Organisme : National Institute for Health Research (NIHR) School for Public Health Research (SPHR)
ID : SPHR-PHD-FUS-002

Références

BMC Public Health. 2020 May 7;20(1):641
pubmed: 32381086
Lancet Public Health. 2020 Apr;5(4):e186-e187
pubmed: 32171054
Psychiatr Serv. 2005 Apr;56(4):475-80
pubmed: 15812100
J Urban Health. 2014 Feb;91(1):33-45
pubmed: 23620012
Res Involv Engagem. 2021 Jan 8;7(1):5
pubmed: 33419484
Lancet Respir Med. 2020 Dec;8(12):1160-1161
pubmed: 32979307
J Subst Abuse Treat. 2016 Feb;61:47-59
pubmed: 26531892
Int J Ment Health Addict. 2020 Jul 9;:1-7
pubmed: 32837440
J Psychoactive Drugs. 2001 Jan-Mar;33(1):27-31
pubmed: 11332998
BMJ. 2020 Feb 24;368:m693
pubmed: 32094110
Psychiatr Serv. 1999 Oct;50(10):1303-8
pubmed: 10506298
Psychiatry Res. 2021 Jun;300:113905
pubmed: 33827013
Health Expect. 2021 May;24 Suppl 1:134-146
pubmed: 32515538
Int J Equity Health. 2021 Jan 10;20(1):29
pubmed: 33423682
Eur J Public Health. 2015 Oct;25(5):879-85
pubmed: 25678604
Addiction. 2020 Jun;115(6):1007-1010
pubmed: 32250482
Eur J Public Health. 2021 Aug 26;:
pubmed: 34436575
Acta Neuropsychiatr. 2004 Feb;16(1):36-40
pubmed: 26983875
BMC Health Serv Res. 2017 Nov 21;17(1):763
pubmed: 29162112
J Epidemiol Community Health. 2006 Oct;60(10):854-7
pubmed: 16973531
Front Psychiatry. 2020 Jul 21;11:714
pubmed: 32848907
Ann Emerg Med. 2003 May;41(5):659-67
pubmed: 12712033
Front Psychol. 2019 Jun 13;10:1052
pubmed: 31263434
Drug Alcohol Depend. 2004 Jun 11;74(3):223-34
pubmed: 15194200
PLoS Med. 2008 Dec 2;5(12):e225
pubmed: 19053169
Nat Med. 2021 Jun;27(6):964-980
pubmed: 34002090
Contemp Clin Trials Commun. 2017 May 05;7:48-56
pubmed: 29696168
BMC Public Health. 2018 Sep 5;18(1):1095
pubmed: 30185163
Community Ment Health J. 2009 Apr;45(2):144-50
pubmed: 18807181
Drug Alcohol Depend. 2011 Apr 1;114(2-3):134-9
pubmed: 20971585
J Health Care Poor Underserved. 2014 Nov;25(4):2053-68
pubmed: 25418259
Int J Public Health. 2012 Aug;57(4):745-50
pubmed: 22297400
BMC Health Serv Res. 2012 Jun 08;12:145
pubmed: 22682145
BMC Med Ethics. 2016 Apr 29;17(1):25
pubmed: 27129927
Lancet. 2017 Mar 4;389(10072):941-950
pubmed: 28271845
Schizophr Res. 2018 Sep;199:154-162
pubmed: 29728293
Int J Drug Policy. 2021 Jan;87:102966
pubmed: 33166825
Evid Based Child Health. 2013 Jul;8(4):1140-272
pubmed: 23877940
J Ment Health. 2021 Jul 29;:1-8
pubmed: 34323635
BMC Health Serv Res. 2012 Jul 27;12:222
pubmed: 22838503
J Subst Abuse Treat. 2000 Sep;19(2):189-98
pubmed: 10963931
BMC Public Health. 2021 Nov 6;21(1):2021
pubmed: 34742267
Harm Reduct J. 2021 Jun 12;18(1):64
pubmed: 34118942
J Behav Health Serv Res. 2010 Apr;37(2):239-51
pubmed: 19768552
BMJ Open. 2021 Jun 3;11(6):e044634
pubmed: 34083333
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
J Psychoactive Drugs. 2008 Nov;Suppl 5:365-76
pubmed: 19248394
Harm Reduct J. 2021 Mar 3;18(1):26
pubmed: 33658042
Harm Reduct J. 2021 Nov 24;18(1):118
pubmed: 34819070
Int J Environ Res Public Health. 2021 May 25;18(11):
pubmed: 34070478
Lancet. 2018 Jan 20;391(10117):241-250
pubmed: 29137869
Health Expect. 2016 Aug;19(4):973-87
pubmed: 26714263

Auteurs

Emma A Adams (EA)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE3 4ES, UK.

Jeff Parker (J)

HeathNow, Crisis, City House 1 City Road, Newcastle upon Tyne NE1 2AF, UK.
Pathway, 4th Floor East, 250 Euston Road, London NW1 2PG, UK.
Crisis Pie Team, 66 Commercial Street, London E1 6LT, UK.

Tony Jablonski (T)

HeathNow, Crisis, City House 1 City Road, Newcastle upon Tyne NE1 2AF, UK.
Pathway, 4th Floor East, 250 Euston Road, London NW1 2PG, UK.
Crisis Pie Team, 66 Commercial Street, London E1 6LT, UK.

Joanne Kennedy (J)

Expert by Experience Network, Fulfilling Lives Newcastle Gateshead, Gateshead NE8 4DY, UK.

Fiona Tasker (F)

Expert by Experience Network, Fulfilling Lives Newcastle Gateshead, Gateshead NE8 4DY, UK.

Desmond Hunter (D)

HeathNow, Crisis, City House 1 City Road, Newcastle upon Tyne NE1 2AF, UK.
Expert by Experience Network, Fulfilling Lives Newcastle Gateshead, Gateshead NE8 4DY, UK.

Katy Denham (K)

Newcastle University Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Claire Smiles (C)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE3 4ES, UK.

Cassey Muir (C)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE3 4ES, UK.

Amy O'Donnell (A)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE3 4ES, UK.

Emily Widnall (E)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK.

Kate Dotsikas (K)

Division of Psychiatry, UCL, London W1T 7BN, UK.

Eileen Kaner (E)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE3 4ES, UK.

Sheena E Ramsay (SE)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE3 4ES, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH